USING AI AND NEUROIMAGING
ADVANCED CLINICAL TRIALS AND THERAPIES
OPTIMIZED THERAPIES
OPTIMAL MEASURES
Qynapse is a medical technology company, spin-off of the CATI consortium of neuroimaging research laboratories.
Qynapse is a medical technology company, spin-off of the CATI consortium of neuroimaging research laboratories.
NEWS
https://www.qynapse.com/wp-content/uploads/2020/08/Image-QyScore-Babinski-July-2020.png
703
1640
ysalledechou
https://www.qynapse.com/wp-content/uploads/2019/06/Qynapse_HD.png
ysalledechou2020-08-06 13:53:512020-08-06 14:01:30Qynapse releases new validation results on QyScore® performance during AAIC 2020 Conference
https://www.qynapse.com/wp-content/uploads/2020/07/AAIC-2020-post-website-v2.png
703
1641
ysalledechou
https://www.qynapse.com/wp-content/uploads/2019/06/Qynapse_HD.png
ysalledechou2020-07-23 06:20:102020-07-23 06:34:05Qynapse is pleased to participate in the 2020 Alzheimer’s Association International Conference virtual event
https://www.qynapse.com/wp-content/uploads/2020/02/QyScore-FDA-approval_image6.png
450
1050
ysalledechou
https://www.qynapse.com/wp-content/uploads/2019/06/Qynapse_HD.png
ysalledechou2020-02-03 14:37:552020-07-16 14:58:27Qynapse receives FDA clearance for QyScore®, a novel imaging software for central nervous system diseases
https://www.qynapse.com/wp-content/uploads/2019/07/AAIC2019.png
450
1050
ddempure
https://www.qynapse.com/wp-content/uploads/2019/06/Qynapse_HD.png
ddempure2019-07-01 15:58:502019-08-14 10:15:57Qynapse exhibits at the 2019 Alzheimer’s Association International Conference (AAIC) in Los Angeles, CA
Qynapse is a medical technology company that unlocks the potential of quantitative imaging and AI to optimize diagnosis, prognosis and longitudinal monitoring of patients with neurological diseases.
